LIVSAYIS Trademark

Trademark Overview

On Thursday, June 11, 2026, a trademark application was filed for LIVSAYIS with the United States Patent and Trademark Office. The USPTO has given the LIVSAYIS trademark a serial number of 99879850. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 11, 2026. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The LIVSAYIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity
livsayis

General Information

Serial Number99879850
Word MarkLIVSAYIS
Filing DateThursday, June 11, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, June 11, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkLIVSAYIS
Goods and ServicesPharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity
Pseudo MarkLIV SAYS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 11, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
US

Trademark Events

Event DateEvent Description
Thursday, June 11, 2026NEW APPLICATION ENTERED
Thursday, June 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 11, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

livsayis pharmaceutical treatment preparations therapy genetic respiratory allergic nephrological autoimmune viral